Harry Simeonidis
CIK 1831767 · Chief Executive Officer · last filed 2026-03-20
Harry Simeonidis is a Chief Executive Officer who has filed 4 SEC Form 4 insider transactions across 2 companies since 2022. The most recent filing, for INBS, was dated Mar 20, 2026. Across all open-market trades the lifetime net is +$284, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $54.9K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
INBS price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
NEW YORK CITY, NY 10017
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| INBS | Chief Executive Officer | 34,540 | $1.59 | $54.9K | $284 | 3 | 2026-03-20 |
| INTELLIGENT BIO SOLUTIONS INC. (GBS) Delisted | President | 80,600 | $0.47 | $38.1K | $0 | 1 | 2022-10-12 |
Recent Filings
4 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-03-20 | INBS | Grant (A) | +30,500 | $0 | EDGAR |
| 2024-09-27 | INBS | Grant (A) | +40,000 | $0 | EDGAR |
| 2023-09-05 | INBS | Buy (P) | +150 | $284 | EDGAR |
| 2022-10-12 | INTELLIGENT BIO SOLUTIONS INC. (GBS) Delisted | Grant (A) | +80,000 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.